These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 1715960)
1. Deficiency of a phosphatidylinositol-anchored cell adhesion molecule influences haemopoietic progenitor binding to marrow stroma in chronic myeloid leukaemia. Gordon MY; Atkinson J; Clarke D; Dowding CR; Goldman JM; Grimsley PG; Siczkowski M; Greaves MF Leukemia; 1991 Aug; 5(8):693-8. PubMed ID: 1715960 [TBL] [Abstract][Full Text] [Related]
2. Severe functional alterations in vitro in CD34(+) cell subpopulations from patients with chronic myeloid leukemia. Chávez-González A; Rosas-Cabral A; Vela-Ojeda J; González JC; Mayani H Leuk Res; 2004 Jun; 28(6):639-47. PubMed ID: 15120942 [TBL] [Abstract][Full Text] [Related]
3. Blast colony-forming cell binding from CML bone marrow, or blood, on stromal layers pretreated with G-CSF or SCF. Gidáli J; László E; Halm G; Fehér I Cell Prolif; 2002 Feb; 35(1):1-7. PubMed ID: 11856174 [TBL] [Abstract][Full Text] [Related]
4. Growth kinetics and blast-colony forming cell binding capacity of stromal cells in various haematological malignancies. el-Khatib Y; Gidáli J; Fehér I; Mód A; Poros A; Hollán S Haematologia (Budap); 1991; 24(2):77-82. PubMed ID: 1816058 [TBL] [Abstract][Full Text] [Related]
5. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia. Lanza F; Bi S; Castoldi G; Goldman JM Leukemia; 1993 Oct; 7(10):1570-5. PubMed ID: 7692192 [TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function. Bhatia R; Wayner EA; McGlave PB; Verfaillie CM J Clin Invest; 1994 Jul; 94(1):384-91. PubMed ID: 7518835 [TBL] [Abstract][Full Text] [Related]
7. Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Gordon MY; Dowding CR; Riley GP; Goldman JM; Greaves MF Nature; 1987 Jul 23-29; 328(6128):342-4. PubMed ID: 3474529 [TBL] [Abstract][Full Text] [Related]
8. Hemopoietic progenitor cell binding to the stromal microenvironment in vitro. Gordon MY; Clarke D; Atkinson J; Greaves MF Exp Hematol; 1990 Aug; 18(7):837-42. PubMed ID: 2379549 [TBL] [Abstract][Full Text] [Related]
9. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients. Einat M; Lishner M; Amiel A; Nagler A; Yarkorli S; Rudi A; Kashman Y; Markel D; Fabian I Exp Hematol; 1995 Dec; 23(14):1439-44. PubMed ID: 8542929 [TBL] [Abstract][Full Text] [Related]
10. Interferon-alpha overrides the deficient adhesion of chronic myeloid leukemia primitive progenitor cells to bone marrow stromal cells. Dowding C; Guo AP; Osterholz J; Siczkowski M; Goldman J; Gordon M Blood; 1991 Jul; 78(2):499-505. PubMed ID: 1906352 [TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha restores normal beta 1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia. Bhatia R; McCarthy JB; Verfaillie CM Blood; 1996 May; 87(9):3883-91. PubMed ID: 8611716 [TBL] [Abstract][Full Text] [Related]
12. L-selectin expression is low on CD34+ cells from patients with chronic myeloid leukemia and interferon-a up-regulates this expression. Martín-Henao GA; Quiroga R; Sureda A; González JR; Moreno V; García J Haematologica; 2000 Feb; 85(2):139-46. PubMed ID: 10681720 [TBL] [Abstract][Full Text] [Related]
13. Granulocyte-macrophage colony-stimulating factor modulation of the inhibitory effect of transforming growth factor-beta on normal and leukemic human hematopoietic progenitor cells. Cashman JD; Eaves AC; Eaves CJ Leukemia; 1992 Sep; 6(9):886-92. PubMed ID: 1518302 [TBL] [Abstract][Full Text] [Related]
14. Lack of evidence for abnormal autocrine or paracrine mechanisms underlying the uncontrolled proliferation of primitive chronic myeloid leukemia progenitor cells. Otsuka T; Eaves CJ; Humphries RK; Hogge DE; Eaves AC Leukemia; 1991 Oct; 5(10):861-8. PubMed ID: 1961020 [TBL] [Abstract][Full Text] [Related]
15. Tyrphostin AG957, a tyrosine kinase inhibitor with anti-BCR/ABL tyrosine kinase activity restores beta1 integrin-mediated adhesion and inhibitory signaling in chronic myelogenous leukemia hematopoietic progenitors. Bhatia R; Munthe HA; Verfaillie CM Leukemia; 1998 Nov; 12(11):1708-17. PubMed ID: 9823945 [TBL] [Abstract][Full Text] [Related]
16. Effect of mutational inactivation of tyrosine kinase activity on BCR/ABL-induced abnormalities in cell growth and adhesion in human hematopoietic progenitors. Ramaraj P; Singh H; Niu N; Chu S; Holtz M; Yee JK; Bhatia R Cancer Res; 2004 Aug; 64(15):5322-31. PubMed ID: 15289338 [TBL] [Abstract][Full Text] [Related]
18. Activation of beta1 integrins on CML progenitors reveals cooperation between beta1 integrins and CD44 in the regulation of adhesion and proliferation. Lundell BI; McCarthy JB; Kovach NL; Verfaillie CM Leukemia; 1997 Jun; 11(6):822-9. PubMed ID: 9177435 [TBL] [Abstract][Full Text] [Related]
19. Deficient cell cycle control in myeloid cells of patients with newly diagnosed chronic myeloid leukemia. Schwab R; Peschel C; Desprès D; Derigs G; Fischer T; Huber C; Aulitzky WE Cytokines Mol Ther; 1995 Dec; 1(4):281-8. PubMed ID: 9384681 [TBL] [Abstract][Full Text] [Related]
20. Increased DR antigen expression by committed hemopoietic progenitor cells but not primitive progenitor cells in chronic myeloid leukemia. Dowding CR; Gordon MY; Goldman JM Exp Hematol; 1988 Mar; 16(3):171-5. PubMed ID: 3422191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]